In their recently published article in Clinical Cancer Research , Lin and colleagues claim that the efficiency for capturing circulating tumor cells (CTC), using their filter-based microdevice, which they hold a patent on, is superior to the Food and Drug Administration (FDA)-cleared CellSearch
No takes yet. Share an insight, caveat, or question.
Attard et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: